Phase I Clinical Trial of Influenza Vaccine (Split Virion), Inactivated (High Dose)

NCT07737106 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Influenza Vaccine (Split Virion), Inactivated (High Dose)
BIOLOGICAL: Influenza Vaccine (Split Virion), Inactivated

Sponsor

Sinovac Biotech Co., Ltd